At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Surgery for breast cancerprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Breast Surgery
In Brief
An observational study evaluating Surgery for breast cancer for Chronic Neuropathic Pain, Postoperative and 4 related conditions. Completed, enrolled 150 participants across 2 sites.
Detailed Summary
To understand pain pathophysiology in terms of risk factors and protective mechanisms ranging from molecular pathways to societal impacts.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Neuropathic Pain, Postoperative, Chronic Pain, Postoperative, Chronic Chemotherapy-induced Neuropathic Pain, Chronic Chemotherapy-induced Pain, Chronic Chemotherapy-induced Peripheral Neuropathy
CountriesDenmark
CollaboratorsDOLORisk Consortium, Aarhus University Hospital
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartAug 2017
Primary CompletionAug 2021
TodayJul 2026
First PostedApr 21, 2017
Enrollment StartAug 15, 2017
Primary CompletionAug 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 9.2 years ago
Interventions
Surgery for breast cancerprocedure
Breast cancer resection performed via lumpectomy or mastectomy with or without sentinal node biopsy and axillary lymph node dissection.